-+ 0.00%
-+ 0.00%
-+ 0.00%

MANNKIND CORP SHARES UP 5.4% PREMARKET AFTER FDA APPROVES CO'S SINGLE-USE AUTOINJECTOR TO TREAT FLUID BUILDUP

Reuters·07/24/2026 10:43:06

Please log in to view news